Researchers have identified 813 possible cancer driver genes, significantly expanding the list of potential therapeutic targets for treating the disease. The genes help cancer cells grow through a non-mutational mechanism known as splicing. According to the study the number of genes affected by alterations in splicing could be as common as those affected by mutation-driven mechanisms when it comes to the development of the disease.